Abstract:An accurate etiological classification is key to optimize secondary prevention after ischemic stroke, but the cause remains undetermined in one third of patients. Several studies pointed out the usefulness of circulating gene expression markers to discriminate cardioembolic (CE) strokes, mainly due to atrial fibrillation (AF), while only exploring them in small cohorts. A systematic review of studies analyzing high-throughput gene expression in blood samples to discriminate CE strokes was performed. Significantly dysregulated genes were considered as candidates, and a selection of them was validated by RT-qPCR in 100 patients with defined CE or atherothrombotic (LAA) stroke etiology. Longitudinal performance was evaluated in 12 patients at three time points. Their usefulness as biomarkers for AF was tested in 120 cryptogenic strokes and 100 individuals at high-risk for stroke. Three published studies plus three unpublished datasets were considered for candidate selection. Sixty-seven genes were found dysregulated in CE strokes. CREM, PELI1, and ZAK were verified to be up-regulated in CE vs LAA (p = 0.010, p = 0.003, p < 0.001, respectively), without changes in their expression within the first 24 h after stroke onset. The combined up-regulation of these three biomarkers increased the probability of suffering from CE stroke by 23-fold. In cryptogenic strokes with subsequent AF detection, PELI1 and CREM showed overexpression (p = 0.017, p = 0.059, respectively), whereas in high-risk asymptomatic populations, all three genes showed potential to detect AF (p = 0.007, p = 0.007, p = 0.015). The proved discriminatory capacity of these gene expression markers to detect cardioembolism even in cryptogenic strokes and asymptomatic high-risk populations might bring up their use as biomarkers.

Signatures of cardioembolic and large-vessel ischemic stroke.

Gene Expression in Peripheral Blood Differs after Cardioembolic Compared with Large-Vessel Atherosclerotic Stroke: Biomarkers for the Etiology of Ischemic Stroke

Prediction of Cardioembolic, Arterial, and Lacunar Causes of Cryptogenic Stroke by Gene Expression and Infarct Location.

Profiles of lacunar and nonlacunar stroke.

Using Extracellular Circulating microRNAs to Classify the Etiological Subtypes of Ischemic Stroke

Gene Expression Profiling of Blood for the Prediction of Ischemic Stroke

RNA expression profiles from blood for the diagnosis of stroke and its causes.

Utilizing RNA sequencing to identify gene expression markers of stroke-causing thrombi origin: A pilot study

Cardioembolic Ischemic Stroke Gene Expression Fingerprint in Blood: a Systematic Review and Verification Analysis

Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans.

Gene expression profiles of ischemic stroke clots retrieved by mechanical thrombectomy are associated with disease etiology

Identification of Dysregulated Mechanisms and Potential Biomarkers in Ischemic Stroke Onset

Stroke-associated pattern of gene expression previously identified by machine-learning is diagnostically robust in an independent patient population

Identification of Hub Genes Associated with Immune Infiltration in Cardioembolic Stroke by Whole Blood Transcriptome Analysis.

Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke

Abstract P656: Cardioembolic Risk Factors and Ischemic Stroke a Mendelian Randomization Analysis

Exploring biomarkers for ischemic stroke through integrated microarray data analysis

Abstract 2948: Ischemic Transient Neurological Events Identified by Immune Response to Cerebral Ischemia

Integrative analysis of transcriptome-wide association study and gene expression profiling identifies candidate genes associated with stroke.

Transient Ischemic Attacks Characterized by RNA Profiles in Blood.